Screener
Regenxbio RGNX CapEx
CapEx at other companies
Other financials
Where this comes from
Reported directly by Regenxbio in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.
The source filing: Regenxbio’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 7:15 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-336725
| Line item | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Purchases of marketable debt securities | (9,839) | (230,298) |
| Maturities of marketable debt securities | 136,882 | 136,020 |
| Sales of marketable debt securities | 11,465 | — |
| Purchases of property and equipment | (1,995) | (1,415) |
| Net cash provided by (used in) investing activities | 136,513 | (95,693) |
| Cash flows from financing activities | ||
| Proceeds from exercise of stock options | 197 | 228 |
| Taxes paid related to net settlement of stock-based awards | (828) | (510) |
Item 1. Financial Statements.
FAQ
- What is Regenxbio's capex?
- Regenxbio (RGNX) reported capex of $760K in Q2 2026.
- How has Regenxbio's capex changed year-over-year?
- Regenxbio's capex increased by 94.4% year-over-year, from $391K to $760K.
- What is the long-term trend for Regenxbio's capex?
- Over 4 years (2021 to 2025), Regenxbio's capex has grown at a -58.8% compound annual growth rate (CAGR), from $84.18M to $2.41M.
- What does capex mean?
- Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.
Ask your AI about Regenxbio's capex.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude